Trials
Search / Trial NCT06442124

The Effect of BMI on Gluteus Maximum Activity in Adulthood With Sacroiliac Dysfunction

Launched by AHRAM CANADIAN UNIVERSITY · Jun 2, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how body mass index (BMI) affects the activity of a muscle in the buttocks, called the gluteus maximus, in adults who have sacroiliac joint dysfunction. Sacroiliac joint dysfunction can cause pain in the lower back and is a common source of discomfort for many people. The researchers want to find out if a person's BMI, which is a measure of body fat based on height and weight, has any effect on how this muscle functions in people suffering from this type of pain.

To participate in the study, individuals need to be between 20 and 40 years old, have a BMI between 20 and 30, and have been experiencing mild to moderate sacroiliac pain for at least one month. Those with certain medical conditions, such as inflammatory diseases, a history of spinal fractures, or neurological disorders, will not be eligible. Participants will help contribute to our understanding of how weight might influence muscle activity in people with sacroiliac dysfunction, which could lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - adulthood with sacroiliac dysfunction
  • Their ages will range from 20-40 years old.
  • Their BMI will be less than 20- 30kg/m2.
  • All of them suffer from mild to moderate degree of sacroiliac pain.
  • The subjects complain from sacroiliac pain for 1 month ago
  • Exclusion Criteria:
  • * Exclusion criteria were a history of any of the following condition:
  • inflammatory diseases or any rheumatic disorders,
  • a history of vertebral fractures
  • surgical spinal fixation.
  • •any neurological disorders like MS

About Ahram Canadian University

Ahram Canadian University is a distinguished educational institution committed to advancing research and innovation in the field of healthcare. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct rigorous research studies that contribute to the understanding of medical treatments and interventions. By fostering collaboration among researchers, healthcare professionals, and industry partners, Ahram Canadian University aims to enhance patient outcomes and drive the development of evidence-based practices in medicine. Through its commitment to ethical standards and scientific integrity, the university plays a pivotal role in shaping the future of healthcare research.

Locations

Giza, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0